Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Risk Percutaneous Coronary Intervention”

158 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 158 results

Post-approval studies (Phase 4)Ended earlyNCT02601664
What this trial is testing

Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery Lesions

Who this might be right for
ArteriosclerosisNear-infrared SpectroscopyPeri-procedural Myocardial Infarction+1 more
North Texas Veterans Healthcare System 3
Not applicableUnknownNCT06690567
What this trial is testing

Clinical Outcomes of Contemporary IMPELLA Devices in Cardiogenic Shock and High-risk Percutaneous Coronary Intervention

Who this might be right for
Cardiogenic ShockPCI PatientsMechanical Circulatory Support
A.O.U. Città della Salute e della Scienza 700
Post-approval studies (Phase 4)UnknownNCT01491061
What this trial is testing

Ranolazine Loading to Prevent PCI-induced Myocardial Injury

Who this might be right for
Coronary Artery Disease
University of Roma La Sapienza 100
Post-approval studies (Phase 4)Study completedNCT00808717
What this trial is testing

Efficacy of High Dose atorvaSTATIN Loading Before Primary Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction (STATIN STEMI)

Who this might be right for
Myocardial InfarctionAngioplastyPercutaneous Coronary
Yonsei University 170
Large-scale testing (Phase 3)Study completedNCT01641510
What this trial is testing

PRAsugrel or clopIdogrel In Acute Coronary SyndromE With CYP2C19 GENEtic Variants

Who this might be right for
Acute Coronary Syndromes
Dong-A University 70
Post-approval studies (Phase 4)UnknownNCT06025071
What this trial is testing

Residual Inflammatory Risk-Guided colcHicine in Elderly Trial

Who this might be right for
Percutaneous Coronary InterventionMultivessel Coronary Artery DiseaseElderly Patients+1 more
Chinese Academy of Medical Sciences, Fuwai Hospital 800
Not applicableStudy completedNCT03796234
What this trial is testing

Multidisciplinary Program Based in High Intensity Interval Training and Dietary Education for Coronary Artery Disease

Who this might be right for
Coronary Artery Disease
University of Valencia 50
Not applicableStudy completedNCT06087575
What this trial is testing

Early Feasibility Study of the Supira System in Patients Undergoing HRPCI

Who this might be right for
Coronary Artery DiseaseHigh-risk Percutaneous Coronary InterventionInterventional Cardiology
Supira Medical 15
Not applicableNot Yet RecruitingNCT07354828
What this trial is testing

Optimization and Validation of Quality Control Indicators for Coronary Revascularization Based on Antiplatelet Therapy

Who this might be right for
Acute Coronary Syndrome (ACS)High Bleeding Risk (HBR)Coronary Artery Disease (CAD)
Shenyang Northern Hospital 3,500
Not applicableActive Not RecruitingNCT07010965
What this trial is testing

SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI

Who this might be right for
High-Risk PCI
magAssist, Inc. 236
Not applicableStudy completedNCT02101411
What this trial is testing

Platelet Reactivity (High On-Treatment Platelet Reactivity) as Guidance for APT (Antiplatelet Therapy) Adjustment After PCI (Percutaneous Coronary Intervention)

Who this might be right for
PRU(Platelet Reactivity Unit)APT(Antiplatelet Therapy)HOTPR(High on Treat Platelet Reactivity)
Taipei City Hospital 334
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Not applicableLooking for participantsNCT06654453
What this trial is testing

The Thrombus Aspiration During PCI After Thrombolysis in STEMI

Who this might be right for
ST-segment Elevation Myocardial Infarction
Shenghua Zhou 3,500
Not applicableStudy completedNCT07294911
What this trial is testing

Predictors of Contrast-induced Acute Renal Injury in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromeContrast-Induced Acute Kidney Injury
Karaganda Medical University 88
Not applicableStudy completedNCT05543096
What this trial is testing

PMCF Study for Cardiology Access Procedures

Who this might be right for
Coronary Artery Disease
Cordis US Corp. 200
Not applicableLooking for participantsNCT06984406
What this trial is testing

Efficacy and Safety of a Beet-Derived Inorganic Nitrate-Based Food Product for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention

Who this might be right for
Contrast-induced Nephropathy Following Percutaneous Intervention (CIN)
National Medical Research Center for Therapy and Preventive Medicine 88
Not applicableLooking for participantsNCT06558474
What this trial is testing

Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation

Who this might be right for
Coronary Artery Disease
Cathreine BV 12,000
Not applicableLooking for participantsNCT07053618
What this trial is testing

Interventional Left Ventricular Assist System for PCI in CHIP Patients

Who this might be right for
High-Risk Percutaneous Coronary Intervention (High-risk PCI)Left Ventricular Assist Devices
Suzhou Hengruihongyuan Medical Technology Co. LTD 286
Not applicableActive Not RecruitingNCT04477603
What this trial is testing

Impella ECP Early Feasibility Study

Who this might be right for
High-risk Percutaneous Coronary Intervention
Abiomed Inc. 100
Large-scale testing (Phase 3)Study completedNCT01465503
What this trial is testing

Novel Approaches in Preventing and Limiting Events III Trial (NAPLES III): Bivalirudin in High-risk Bleeding Patients

Who this might be right for
Bleeding
Clinica Mediterranea 837
Load More Results